BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32611891)

  • 1. Current Status of Surgery in Management of Prolactinomas.
    Panigrahi MK; Chandrasekhar YBVK; Vooturi S
    Neurol India; 2020; 68(Supplement):S39-S43. PubMed ID: 32611891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Surgery in the Management of Prolactinomas.
    Donoho DA; Laws ER
    Neurosurg Clin N Am; 2019 Oct; 30(4):509-514. PubMed ID: 31471058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.
    Soule SG; Farhi J; Conway GS; Jacobs HS; Powell M
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):711-6. PubMed ID: 8759184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of prolactinomas: cons.
    Bloomgarden E; Molitch ME
    Endocrine; 2014 Dec; 47(3):730-3. PubMed ID: 25112227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
    Andereggen L; Frey J; Andres RH; El-Koussy M; Beck J; Seiler RW; Christ E
    Endocrine; 2017 Jan; 55(1):223-230. PubMed ID: 27688009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP.
    Donegan D; Atkinson JL; Jentoft M; Natt N; Nippoldt TB; Erickson B; Meyer F; Erickson D
    Endocr Pract; 2017 Jan; 23(1):37-45. PubMed ID: 27682355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
    Hamilton DK; Vance ML; Boulos PT; Laws ER
    Pituitary; 2005; 8(1):53-60. PubMed ID: 16411069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approach to treatments for prolactinomas.
    Tirosh A; Shimon I
    Minerva Endocrinol; 2016 Sep; 41(3):316-23. PubMed ID: 26399371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of prolactinomas.
    Molitch ME; Thorner MO; Wilson C
    J Clin Endocrinol Metab; 1997 Apr; 82(4):996-1000. PubMed ID: 9100563
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of Transsphenoidal Microsurgery for Prolactinomas - A Contemporary Series of 162 Cases.
    Giese S; Nasi-Kordhishti I; Honegger J
    Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):163-171. PubMed ID: 33461233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term management of prolactinomas--use of long-acting dopamine agonists.
    Cook DM
    Rev Endocr Metab Disord; 2005 Jan; 6(1):15-21. PubMed ID: 15711910
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of resistant prolactinomas.
    Olafsdottir A; Schlechte J
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):552-61. PubMed ID: 17024154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of cystic prolactinomas: a review.
    Nakhleh A; Shehadeh N; Hochberg I; Zloczower M; Zolotov S; Taher R; Daoud Naccache D
    Pituitary; 2018 Aug; 21(4):425-430. PubMed ID: 29654440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of prolactinomas during pregnancy.
    Witek P; Zieliński G
    Minerva Endocrinol; 2013 Dec; 38(4):351-63. PubMed ID: 24285103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transsphenoidal surgery for a life-threatening prolactinoma apoplexy during pregnancy.
    Witek P; Zieliński G; Maksymowicz M; Zgliczyński W
    Neuro Endocrinol Lett; 2012; 33(5):483-8. PubMed ID: 23090264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Treatment of Prolactinomas: Potential Role as a First-Line Treatment Modality.
    Kim EH; Kim J; Ku CR; Lee EJ; Kim SH
    Yonsei Med J; 2023 Aug; 64(8):489-496. PubMed ID: 37488700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucocele-like formation leading to neurological symptoms in prolactin-secreting pituitary adenomas under dopamine agonist therapy.
    Abe T; Lüdecke DK
    Surg Neurol; 1999 Sep; 52(3):274-9. PubMed ID: 10511086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current indications for the surgical treatment of prolactinomas.
    Smith TR; Hulou MM; Huang KT; Gokoglu A; Cote DJ; Woodmansee WW; Laws ER
    J Clin Neurosci; 2015 Nov; 22(11):1785-91. PubMed ID: 26277642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of prolactinomas.
    Molitch ME
    Endocrinol Metab Clin North Am; 1999 Mar; 28(1):143-69, vii. PubMed ID: 10207689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operative treatment of cystic prolactinomas: a retrospective study.
    Su W; He K; Yang Y; Xu J; Li X; Tang H; Yang J; Yang L
    BMC Endocr Disord; 2023 May; 23(1):99. PubMed ID: 37143054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.